Advanced biopharmaceutical research and development focusing on biologic medicines, monoclonal antibodies, and protein-based therapeutics. This segment leverages cutting-edge biotechnology to develop targeted treatments for complex diseases.

Strategic business innovation including new therapeutic areas, technology platforms, and business model development. This segment drives long-term growth and competitive advantage.